Related Experiment Video
Updated: Dec 23, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
693
Psoriasis and Cardiovascular Risk: A Comprehensive Review
Walter Masson1,2, Martín Lobo3, Graciela Molinero3
1Hospital Italiano de Buenos Aires, Perón 4190, C1199ABB, Buenos Aires, Argentina. walter.masson@hospitalitaliano.org.ar.
Advances in Therapy
|April 22, 2020
Summary
Psoriasis patients face higher cardiovascular risks due to systemic inflammation and metabolic issues. Effective cardiovascular risk management is crucial for this population.
Area of Science:
- Immunology
- Dermatology
- Cardiology
Background:
- Psoriasis is a systemic inflammatory disease linked to immune system dysregulation.
- Patients with psoriasis exhibit a higher incidence of cardiovascular disorders.
- Cardiovascular disease risk is elevated in psoriasis patients due to inflammation and metabolic factors.
Purpose of the Study:
- To review evidence linking psoriasis to cardiovascular risk factors and disease.
- To explore pathophysiological mechanisms behind this association.
- To analyze cardiovascular risk stratification and prevention strategies in psoriasis.
Main Methods:
- Epidemiologic and clinical evidence review.
- Analysis of pathophysiological mechanisms.
- Evaluation of cardiovascular prevention therapies and psoriasis medication impact.
Main Results:
- Psoriasis is associated with traditional cardiovascular risk factors and metabolic abnormalities.
- Systemic inflammation and metabolic issues may synergistically increase cardiovascular risk.
- Specific psoriasis treatments may influence cardiovascular risk factors.
Conclusions:
- Understanding the link between psoriasis and cardiovascular disease is vital.
- Comprehensive cardiovascular risk assessment and management are essential for psoriasis patients.
- Targeted prevention strategies can mitigate cardiovascular burden in psoriasis.
Related Concept Videos
01:27Psychoneuroimmunology: Cardiovascular Disease
276
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
276
01:26Atherosclerosis III: Management
263
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
01:30Coronary Artery Disease I: Introduction
781
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781
01:23Assessment of the Cardiovascular System I: Subjective Data
690
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
690
01:23Rheumatic Heart Disease I: Introduction
332
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
332
01:21Rheumatic Heart Disease III: Medical Management
218
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
218